Perspective Therapeutics, Inc. (ISR) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Electromed, Inc.

Apyx Medical Corp.

DarioHealth Corp.

Citius Pharmaceuticals, Inc.

Accelerate Diagnostics, Inc.

CytoSorbents Corp.

Cutera, Inc.

Perspective Therapeutics, Inc.

Monogram Orthopaedics, Inc.

Vicarious Surgical, Inc.

T2 Biosystems, Inc.

Why is Perspective Therapeutics, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-37.64%

EBIT Growth (5y)

-294.15%

EBIT to Interest (avg)

-26.45

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.73

Sales to Capital Employed (avg)

0.03

Tax Ratio

2.42%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

64.46%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.24

EV to EBIT

-3.10

EV to EBITDA

-3.20

EV to Capital Employed

4.98

EV to Sales

321.22

PEG Ratio

Dividend Yield

ROCE (Latest)

-160.46%

ROE (Latest)

-45.23%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

NET PROFIT(HY)

Higher at USD -53.68 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 9.09 times

-19What is not working for the Company

NET SALES(HY)

At USD 0.12 MM has Grown at -79.34%

NET PROFIT(HY)

At USD -53.68 MM has Grown at -56.84%

INTEREST(HY)

At USD 0.17 MM has Grown at 32.03%

RAW MATERIAL COST(Y)

Grown by 1,101.83% (YoY

Here's what is working for Perspective Therapeutics, Inc.

Net Profit

Higher at USD -53.68 MM

than preceding 12 month period ended Mar 2026

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Debtors Turnover Ratio

Highest at 9.09 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Depreciation

Highest at USD 1.13 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Perspective Therapeutics, Inc.

Net Sales

At USD 0.12 MM has Grown at -79.34%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (USD MM)

Net Profit

At USD -53.68 MM has Grown at -56.84%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Interest

At USD 0.17 MM has Grown at 32.03%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Raw Material Cost

Grown by 1,101.83% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales